Slower administration of propofol preserves adequate respiration in children

Maryam Dosani1, Jon McCormack, Eleanor Reimer

  • 1Department of Anesthesiology, Pharmacology and Therapeutics, The University of British Columbia, Vancouver, BC, Canada.

Paediatric Anaesthesia
|October 1, 2010
PubMed

Insights

Slower propofol infusion rates in children undergoing procedures can maintain spontaneous breathing. This study developed a dosing schedule to reduce respiratory depression risk during anesthesia.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Respiratory Physiology

Background:

  • Propofol is a common anesthetic for pediatric procedures.
  • Propofol administration can lead to significant respiratory depression.
  • Safe propofol dosing is crucial to preserve spontaneous respiration in children.

Purpose of the Study:

  • To develop a propofol dosing schedule for pediatric patients.
  • To ensure spontaneous respiration is maintained in at least 95% of subjects.
  • To enhance the safety of propofol administration in pediatric procedural sedation.

Main Methods:

  • Children aged 6-15 years (ASA Status I-II) undergoing endoscopy were enrolled.
  • A two-phased study involved an intravenous loading dose of propofol (4 mg·kg(-1)).
  • Infusion rates were adjusted based on respiratory response, with Phase II using a Biased Coin Design to find the 95% respiratory insufficiency threshold.

Main Results:

  • Fifty subjects were analyzed, with infusion rates varying from 1000 to 2300 mcg·kg(-1)·min(-1).
  • Seven subjects experienced respiratory insufficiency, with a mean time to onset of 104 seconds.
  • A propofol loading dose administered over 3.0 minutes (CI = 1.9-3.4 min) maintained spontaneous respiration in 95% of pediatric subjects.

Conclusions:

  • The respiratory response to propofol varies significantly among children.
  • Administering propofol at slower infusion rates reduces the risk of respiratory depression.
  • The study identified a specific loading dose duration to maintain spontaneous respiration in most pediatric patients.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...